NewsRoom Articles - Page 175 of 604

FridayJul 15, 2022 4:20 am

420 with CNW — Health Canada Remains Quiet on Timeline for Reviewing Marijuana Law

More than eight months after the Canadian government was supposed to begin a review of Canada’s 2018 adult-use legalization law, authorities have yet to begin the process. Additionally, Health Canada, the department in charge of the country’s national health policy, still hasn’t provided a timeline for reviewing the recreational cannabis law. This delay has hindered the development of much-needed legislative reforms for the recreational cannabis industry, one industry executive believes. According to Aurora Cannabis senior vice president of global government relations Rick Savone, the legislative review needs to cover a lot before the industry can get the regulations it desperately…

ThursdayJul 14, 2022 4:20 pm

420 with CNW — Connecticut Company Leverages DEA License to Supply Marijuana for Yale Research

CT Pharma, a Connecticut-based medical marijuana production and research company, made history in 2019 when the U.S. Drug Enforcement Administration allowed it to grow marijuana for FDA-approved research. It became the first state-licensed cannabis company that could legally provide cannabis for studies funded by the federal government, breaking the University of Mississippi’s monopoly on cultivating research-grade cannabis. The university had been the only federally approved supplier of cannabis for years. Still, researchers regularly complained that the cannabis produced by the facility was low-grade and compromised the results of their studies. In a move that is sure to be approved by…

ThursdayJul 14, 2022 9:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) DehydraTECH(TM) Licensee Expands Manufacturing Agreements to Include Europe, Japan, and South Africa

Lexaria's patented DehydraTECH(TM) enhancement technology targets key market segments including nicotine replacement, CBD, cardiovascular and antiviral drugs, human hormones, and PDE5 inhibitors DehydraTECH-enabled drug and consumer products provide faster delivery times, increased bioavailability, increased brain absorption, improved drug potency, lower administration costs, and mask unwanted tastes The global CBD market was valued at $5.18 billion in 2021 and is expected to grow at a CAGR of 16.8% from 2022 to 2030, resulting in a revenue forecast of $22.05 billion by 2030 Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, has announced that Boldt Runners Corporation, licensee of…

ThursdayJul 14, 2022 4:20 am

420 with CNW — Senators Express Disappointment with President Biden’s Failure to Enact Marijuana Reforms

President Joseph Biden based part of his campaign on marijuana reform, stating that he would pursue marijuana decriminalization and the expungement of prior cannabis-related offenses. However, one-and-a-half years after he took office, the Biden administration has barely taken any action to keep the president’s marijuana promises. This inaction has been met with criticism and disappointment from drug reform activists and lawmakers. Six U.S. senators recently renewed their call for the president to fulfill his cannabis promises, specifically de-scheduling cannabis and granting mass pardons to people currently incarcerated for cannabis offenses. Furthermore, they said that the Justice Department’s response to a…

WednesdayJul 13, 2022 4:20 pm

420 with CNW — DC Mayor Enacts Measure Allowing Patients to Self-Certify as Medical Cannabis Patients

Dozens of states in the United States have now legalized medical cannabis use. In most of these territories, qualifying patients have to receive a recommendation from their doctor before accessing medical marijuana. In Washington, DC, however, patients will now be able to certify themselves as medical cannabis patients without a physician's recommendation after the mayor recently signed emergency legislation into law. The district council approved the measure unanimously last week in a 13 to 0 vote. The emergency bill effectively allows the council to work around a congressional rider that forbids the district from using federal dollars to launch a…

WednesdayJul 13, 2022 4:20 am

420 with CNW — Marijuana Consumption Lounges May Open in Nevada by Year’s End

Adults aged 21 and older in Nevada may soon be able to use cannabis products publicly in cannabis consumption lounges by the end of the year after the Cannabis Compliance Board approved regulations for the consumption sites. Although Nevada launched the recreational cannabis market back in 2017, the state only allows adults to consume the substance in private homes. This is despite the fact that Nevada’s cannabis industry has been a big draw for tourists, with plenty of visitors coming from out of state to sample products from cannabis retailers in Las Vegas. The result is that tourists are allowed…

TuesdayJul 12, 2022 4:20 pm

420 with CNW — US Army Explores Using Hemp to Manufacture Sniper Uniforms

Long before authorities outlawed the cultivation, processing and sale of hemp, fabrics made from hemp were all the rage. People have used hemp fabrics in a wide variety of applications for hundreds of years, with its strength and coarseness making it a perfect fabric for ship sailcloths, canvas, rope, socks and even paper. Sailors of old also used hemp cordage to hold ships and sails. The U.S. Army is now exploring ways it can use industrial hemp to develop uniforms for snipers. This is despite the fact that service members are absolutely prohibited from using federally legal CBD that has…

TuesdayJul 12, 2022 10:30 am

Lexaria Bioscience Corp.’s (NASDAQ: LEXX) DehydraTECH(TM) Technology Enhances Bioavailability of Orally Administered APIs

Lexaria is a global innovator in drug delivery platforms The company has developed the patented DehydraTECH(TM) technology that significantly improves the bioavailability of orally administered pharmaceuticals and therapeutics Bioavailability is the fraction of a drug that reaches the site of action or systemic circulation While drugs delivered intravenously are 100% bioavailable, drugs that have any other route of administration, such as oral, have reduced bioavailability DehydraTECH enhances the bioavailability of APIs, in part, by bypassing first-pass liver processing Global innovator Lexaria Bioscience (NASDAQ: LEXX) has built a reputation as a developer of drug delivery platforms, the most notable of which…

TuesdayJul 12, 2022 4:20 am

420 with CNW — How Marijuana Retailers Preserve the Quality of Concentrates During Storage

Learning proper storage techniques is crucial for cannabis businesses, especially those looking to succeed in the highly competitive and cutthroat cannabis concentrates segment. Storing cannabis flower isn’t difficult, but improper storage can steadily degrade the cannabis and even lead to the growth of mold. Concentrates, on the other hand, require high-quality storage techniques because they are more sensitive to degradation compared to flower and edibles. Marijuana concentrates will begin to degrade quickly when exposed to the elements. This means that storing cannabis concentrates products poorly for even a couple of hours could severely degrade them and cause them to change…

MondayJul 11, 2022 4:20 pm

420 with CNW — Germany Primarily Focuses on Safety in Cannabis Legalization Plans

Like many territories across the world, Germany is on the way to legalizing the use of recreational cannabis for adults. Although the substance has provided American states with billions of dollars in taxes and can be extremely profitable for Germany, the European country is planning on taking a “safety first” approach that prioritizes public health and safety. German Health Minister Karl Lauterbach recently revealed that the government is set on legalizing recreational cannabis and already has a draft law that is expected to be ready by the end of 2022. He stated that the legislation has been long awaited and…

News and publishing service for cannabis related companies

Contact us: 512.354.7000